Vanguard Group sells shares of 7 companies worth Rs 998 cr
US-based financial services company Vanguard Group on Friday bought shares of seven companies including Concord Biotech, Five-Star Business Finance and Marksans Pharma for Rs 998 crore through open ma
Vanguard Group Acquires Rs 998 Crore in Indian Companies
US-based financial services company Vanguard Group acquired shares worth Rs 998 crore in seven Indian companies via open market transactions on the NSE. Concurrently, Zurich-based UBS Group AG sold shares worth Rs 479.
Vanguard Group Buys Rs 998 Cr Shares in 7 Companies
Vanguard Group, a US-based financial services company, has purchased shares in seven Indian companies, including Concord Biotech and Five-Star Business Finance, for a total of Rs 998 crore.
Bulk deals : Vanguard Group buys shares worth Rs 1000 crore in 7 companies
On September 20, The Vanguard Group Inc A/C Vanguard Total International Stock Index Fund, The Vanguard Group Inc A/C Vanguard Emerging Markets Stock Index Fund A Series of Vanguard International, and UBS Principal Capital Asia Limited bought and sold stakes in various companies via bulk deals.
UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals
UBS sold holdings in Concord Biotech, Five Star Business Finance, IIFL Securities, and Marksans Pharma through block deals, totaling Rs 480 crore. The largest sale was in Concord Biotech, worth Rs 192 crore at a 15% premium.
Vanguard sells shares of 7 companies worth Rs 998 cr via block deals
US-based financial services company Vanguard Group on Friday bought shares of seven companies including Concord Biotech, Five-Star Business Finance and Marksans Pharma for Rs 998 crore through open market transactions.
Vanguard Group Acquires Nearly Rs 1,000 Crore In Shares Across Seven Companies
The Vanguard Group bought shares worth Rs 997.8 crore in seven companies through its affiliates on Friday. Arvind Fashions Ltd.: The Vanguard Group bought 6.71 lakh shares or a 0.5% stake for Rs 39.6 crore. Concord Biotech Ltd.: The Vanguard Group obtained 5.77 lakh shares or a 0.55% stake for Rs 149.8 crore.
Number of smallcap stocks offering double-digit returns falls even as bulls dominate the week
Despite the overall positive market sentiment, the rally didn't fully extend to small-cap stocks. This is evident in the ...
thearabianpost7h
Vanguard Group Invests Rs 998 Crore in Seven Firms
Dubai A significant investment has emerged from the Vanguard Group, a leading US-based financial services company, which has ...
money.rediff9mon
Concord Biotech Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 on 18th September, 2024.
Stock market update: Stocks that hit 52-week highs on NSE in today's trade
Marksans Pharma, Concord Biotech Ltd., Interarch Building and Themis Medicare, hit their fresh 52-week highs during the day.